IE 11 is a very old Browser and it`s not supported on this site
de en
Interim report as at 31.03.2024
de en
Business reportPerformance / Multi-year comparison
Business Report Performance

Performance/Multi-year comparison

Indexed performance since launch

BB Biotech AG (SIX)-CHF


Rolling performance

SHARE

NAV

NBI TR

31.03.2023 – 31.03.2024

(4.8%)

13.5%

6.8%

31.03.2022 – 31.03.2023

(18.4%)

(11.2%)

(1.1%)

31.03.2021 – 31.03.2022

(16.7%)

(23.6%)

(13.0%)

31.03.2020 – 31.03.2021

63.3%

67.9%

36.7%

29.03.2019 – 31.03.2020

(19.5%)

(26.6%)

(5.8%)

Annual performance

SHARE

NAV

NBI TR

2023

(18.1%)

(7.4%)

(4.8%)

2022

(24.3%)

(11.0%)

(9.1%)

2021

8.3%

(11.5%)

3.0%

2020

19.3%

24.3%

15.8%

2019

18.5%

23.4%

23.0%

Cumulated performance

31.03.2024

SHARE

NAV

NBI TR

YTD

11.3%

11.2%

9.1%

1 year

(4.8%)

13.5%

6.8%

3 years

(35.3%)

(23.0%)

(8.1%)

5 years

(14.9%)

(5.1%)

18.4%

10 years

141%

111%

94%

since inception 1)

2 103%

2 080%

1 313%

1 09.11.1993

Annualized performance

31.03.2024

SHARE

NAV

NBI TR

1 year

(4.8%)

13.5%

6.8%

3 years

(13.5%)

(8.3%)

(2.8%)

5 years

(3.2%)

(1.0%)

3.4%

10 years

9.2%

7.8%

6.8%

since inception 1)

10.7%

10.7%

9.1%

1 09.11.1993

BB BIOTECH AG (XETRA)-EUR


Rolling performance

SHARE

NAV

NBI TR

31.03.2023 – 31.03.2024

(2.1%)

15.8%

9.0%

31.03.2022 – 31.03.2023

(17.4%)

(8.6%)

1.8%

31.03.2021 – 31.03.2022

(9.4%)

(17.2%)

(5.8%)

31.03.2020 – 31.03.2021

58.5%

60.7%

30.8%

29.03.2019 – 31.03.2020

(16.2%)

(22.6%)

(0.6%)

Annual performance

SHARE

NAV

NBI TR

2023

(15.2%)

(1.3%)

1.3%

2022

(19.0%)

(6.7%)

(4.5%)

2021

13.3%

(7.8%)

7.4%

2020

18.1%

24.8%

16.1%

2019

23.4%

28.1%

27.6%

Cumulated performance

31.03.2024

SHARE

NAV

NBI TR

YTD

7.6%

6.3%

4.1%

1 year

(2.1%)

15.8%

9.0%

3 years

(26.7%)

(12.3%)

4.5%

5 years

(2.7%)

9.0%

35.9%

10 years

200%

165%

142%

since inception 1)

1 863%

1 846%

1 427%

1 10.12.1997

Annualized performance

31.03.2024

SHARE

NAV

NBI TR

1 year

(2.1%)

15.8%

9.0%

3 years

(9.8%)

(4.3%)

1.5%

5 years

(0.5%)

1.7%

6.3%

10 years

11.6%

10.2%

9.2%

since inception 1)

12.0%

11.9%

10.9%

1 10.12.1997

Multi-year comparison

31.03.2024

2023

2022

2021

2020

Market capitalization at the end of the period (in CHF mn)

2 523.5

2 368.4

3 058.1

4 274.1

4 107.9

highchart-toggle

Net Asset Value at the end of the period (in CHF mn)

2 474.0

2 323.2

2 686.1

3 283.5

3 887.5

highchart-toggle

Number of shares (in mn)

55.4

55.4

55.4

55.4

55.4

highchart-toggle

Trading volume (in CHF mn)

263.5

906.3

1 482.0

2 101.0

2 315.6

highchart-toggle

Profit/(loss) (in CHF mn)

260.5

(206.6)

(357.8)

(404.8)

691.2

highchart-toggle

Closing price at the end of the period in CHF

45.55

42.75

55.20

77.15

74.15

highchart-toggle

Closing price at the end of the period in EUR

46.90

45.50

56.70

74.05

68.00

highchart-toggle

Stock performance (incl. distributions) 1)

11.3%

(18.1%)

(24.3%)

8.3%

19.3%

highchart-toggle

High/low share price in CHF

49.35/42.60

60.70/35.60

78.15/51.00

92.20/73.40

74.70/45.44

highchart-toggle

High/low share price in EUR

52.00/44.90

60.50/37.10

75.40/49.60

86.20/67.80

69.00/43.04

highchart-toggle

Premium/(discount) (annual average)

1.0%

7.5%

20.5%

19.5%

9.2%

highchart-toggle

Dividend in CHF

N.A.

2.00

2.85

3.85

3.60

highchart-toggle

Degree of investment (quarterly figures)

114.1%

113.7%

112.8%

108.6%

106.8%

highchart-toggle

Total Expense Ratio (TER) p.a. 2)

1.35%

1.34%

1.27%

1.22%

1.25%

highchart-toggle

1All figures in CHF %, total return-methodology

2Based on market capitalization

BB Biotech AG uses cookies to improve website usability and ensure the best possible user experience. Use of cookies & disclaimer
Accept cookies